Sule

EE - ET


Please select a country and, if applicable, a language.

Eneseravi on tervishoius olulisel kohal

… nagu ka arsti poolt määratud ravi puhul, tuleb eneseravi teostada saadaolevate tõendite alusel. Evidence for Self-Medication (EfSM) esitab kompaktse ülevaate käsimüügiravimite ja aktiivsete toimeainete asjakohastest uuringutest, et anda apteekritele ning teistele tervishoiutöötajatele eneseravi kohta parimat ja tõendipõhist nõu . 

 

Kõik EfSM-i artiklid on läbinud eksperthindamise. Artiklid on saadaval saksa ja inglise keeles ning mitmed ka teistes keeltes.

How community pharmacists facilitate optimal constipation self-management


Constipation, a common ailment, often finds its first line of management at a community pharmacy. As the relevance of self-medication increases, pharmacists play a pivotal role in patient education, primary consultation, and evidence-based treatment recommendations. A crucial aspect of this role is offering relief while recognizing when to suggest additional medical consultation [1].

Ava artikkel
Autor: Christian Ude, Eric Martin, Dilhan Esen ja Daniel PohlEFSM: 2024;4:240053DOI: 10.52778/efsm.24.0053Kuupäev: 11.11.2024

Acetylsalicylic acid 1,000 mg: strong evidence and good tolerability in acute headache management


Headaches are most prevalent in middle age and not only have an immediate impact on the quality of life of those affected but also significantly influence their work and overall productivity. The majority of sufferers manage acute headaches through self-medication. National and international guidelines recommend acetylsalicylic acid (ASA) as a first-line treatment, with the scientific evidence for ...

Ava artikkel
Autor: Jens SeibelEFSM: 2024;4:240051DOI: 10.52778/efsm.24.0051Kuupäev: 17.10.2024

Deciphering the daily disruption of cough: the role of ambroxol in patient recovery and quality of …


Ambroxol is a mucoactive agent which has been widely used to treat acute and chronic respiratory diseases associated with a disturbance of mucus formation and transport. More recent data demonstrated that acute and chronic cough have also significant negative impact on the daily lives of adults and children. This article evaluates the impact of ambroxol on cough recovery speed and quality of life, ...

Ava artikkel
Autor: Heidemarie Graeter, Lara Jagwanth ja Anne-Laure TardyEFSM: 10.52778/efsm.24.0045DOI: 10.52778/efsm.24.0045Kuupäev: 16.10.2024

Are all stimulant laxatives the same?  A comparative perspective on bisacodyl, sodium …


Stimulant laxatives, such as bisacodyl, sodium picosulfate (SPS), and senna, are recommended to treat constipation, based on the recent AGA/ACG guideline [1], with different levels of recommendation and evidence. They all stimulate intestinal motility, as well as water and electrolyte secretion, and accelerate intestinal transit time [2, 3]. Herbal laxatives cannot be generalized to be gentler com ...

Ava artikkel
Autor: Maura Corsetti, Anna Lacerda, Ketu Patel ja Alèxia AranEFSM: 2024;4:240040DOI: 10.52778/efsm.24.0040Kuupäev: 15.09.2024

The importance of real-world evidence (RWE) using the example of a diclofenac pain relief gel and a…


Real-world evidence (RWE) studies are gaining increasing importance in medical research because they investigate drug therapy use under everyday conditions. Two recent RWE studies in the field of self-medication exemplify the added value that this methodology offers for the evaluation of medicinal products.

Ava artikkel
Autor: Dr Markus ZieglmeierEFSM: 2024;4:240035DOI: 10.52778/efsm.24.0035Kuupäev: 30.07.2024

EfSM Uudiskiri


Liituge meie uudiskirjaga ja olge kursis kõige värskemate EfSM-i väljaannetega.

Liituge siin

Esiletõstetud artikkel

New scientific findings on the mucokinetic effect of ambroxol


Ambroxol increases cilia beating in the airways to remove the mucus. A new study has shed light on further details of the signalling pathway responsible for the mucokinetic action.

Ava artikkel